Microemulsion-based approach for oral delivery of insulin: formulation design and characterization
- PMID: 32258491
- PMCID: PMC7113630
- DOI: 10.1016/j.heliyon.2020.e03650
Microemulsion-based approach for oral delivery of insulin: formulation design and characterization
Abstract
Oral delivery of insulin provides a good alternative because it is non-invasive and patient-friendly. However, multiple challenges affected this route. To overcome barriers for oral delivery of insulin, we aimed to develop a novel insulin-loaded microemulsion system based on snail mucin for oral administration. The strategy in the novel system of using mucin loading insulin into the inner core of prepared water in oil microemulsion to provide sustained released, increased in vivo stability and enhanced drug absorption in the gastrointestinal tract. We report how microemulsion composed of varying ratios of snail mucin and Tween® 80 (1:9-9:1) using oil/water emulsion preparation method influenced insulin performance after oral administration. The results obtained include an encapsulation efficiency of above 70 %; in vitro release was sustained over 10 h and in vivo evaluations in diabetic rat model shows that insulin-loaded microencapsulation effectively reduced blood glucose levels over a period >8 h after oral administration. Therefore, we suggest that the developed formulation for oral insulin can be a promising alternative dosage form for oral protein delivery.
Keywords: Biological sciences; Biotechnology; Diabetes; Materials application; Materials characterization; Microemulsions; Mucin; Oral-insulin; Pharmaceutical chemistry; Pharmacology; Tween® 80.
© 2020 Published by Elsevier Ltd.
Figures




Similar articles
-
Surface-modified mucoadhesive microparticles as a controlled release system for oral delivery of insulin.Heliyon. 2019 Sep 12;5(9):e02366. doi: 10.1016/j.heliyon.2019.e02366. eCollection 2019 Sep. Heliyon. 2019. PMID: 31535040 Free PMC article.
-
Development and In vitro and In vivo Evaluations of a Microemulsion Formulation for the Oral Delivery of Oxaprozin.Curr Drug Deliv. 2022;19(3):347-356. doi: 10.2174/1567201818666210914092745. Curr Drug Deliv. 2022. PMID: 34521326
-
In-vitro release and oral bioactivity of insulin in diabetic rats using nanocapsules dispersed in biocompatible microemulsion.J Pharm Pharmacol. 2002 Apr;54(4):473-80. doi: 10.1211/0022357021778736. J Pharm Pharmacol. 2002. PMID: 11999123
-
Microemulsion utility in pharmaceuticals: Implications for multi-drug delivery.Int J Pharm. 2017 Jun 30;526(1-2):425-442. doi: 10.1016/j.ijpharm.2017.05.005. Epub 2017 May 7. Int J Pharm. 2017. PMID: 28495500 Review.
-
Applications of microemulsion based drug delivery system.Curr Drug Deliv. 2006 Jul;3(3):267-73. doi: 10.2174/156720106777731118. Curr Drug Deliv. 2006. PMID: 16848728 Review.
Cited by
-
The Current and Promising Oral Delivery Methods for Protein- and Peptide-Based Drugs.Int J Mol Sci. 2024 Jan 9;25(2):815. doi: 10.3390/ijms25020815. Int J Mol Sci. 2024. PMID: 38255888 Free PMC article. Review.
-
Oral delivery of protein and peptide drugs: from non-specific formulation approaches to intestinal cell targeting strategies.Theranostics. 2022 Jan 1;12(3):1419-1439. doi: 10.7150/thno.61747. eCollection 2022. Theranostics. 2022. PMID: 35154498 Free PMC article. Review.
-
Challenges and opportunities in delivering oral peptides and proteins.Expert Opin Drug Deliv. 2023 Jul-Dec;20(10):1349-1369. doi: 10.1080/17425247.2023.2237408. Epub 2023 Jul 17. Expert Opin Drug Deliv. 2023. PMID: 37450427 Free PMC article. Review.
-
Muco-Adhesive and Muco-Penetrative Formulations for the Oral Delivery of Insulin.ACS Omega. 2024 May 29;9(23):24121-24141. doi: 10.1021/acsomega.3c10305. eCollection 2024 Jun 11. ACS Omega. 2024. PMID: 38882129 Free PMC article. Review.
-
Effects of piperine on intestinal permeation, pharmacodynamics and pharmacokinetics of insulin loaded chitosan coated solid lipid nanoparticles in rats.Sci Rep. 2025 Jul 2;15(1):22771. doi: 10.1038/s41598-025-05137-3. Sci Rep. 2025. PMID: 40594447 Free PMC article.
References
-
- Abdallah M., Yuichi T., Hirofumi T. Design and evaluation of novel pH-sensitive chitosan nanoparticles fororal insulin delivery. Eur. J. Pharmaceut. Sci. 2011;42:445–451. - PubMed
-
- Adikwu M.U., Aneke K.O., Builders P.F. Biophysical properties of mucin and its use as a mucoadhesive agent in drug delivery: current development and future concepts. Niger. J. Pharmaceut. Res. 2005;4:60–69.
-
- Al-Salami H. Probiotics decreased the bioavailability of the bile acid analog, monoketocholic acid, when coadministered with gliclazide, in healthy but not diabetic rats. Eur. J. Drug Metab. Pharmacokinet. 2012;37(2):99–108. - PubMed
-
- Amidi M.E., Mastrobattista W., Jiskoot W.E. Chitosan-baseddelivery systems for protein therapeutics and antigens. Adv. Drug Deliv. Rev. 2010;62:59–82. - PubMed
-
- Arhewoh M.I., Eraga S.O., Maroh O. Transdermal delivery of bovine serum albumin using snail mucin.East and central. Afr. J. Pharmaceut. 2014;17:18–24.
LinkOut - more resources
Full Text Sources
Research Materials